Established in 1998, we specialize in supplying customers in the healthcare sector with a modern API product range along with intermediates, supporting Paragraph IV, FTF, NDA, 505b2, ANDA and Dossier submissions through supply partnerships, and providing assistance in regulatory paths.
Trichem serves a wide range of customers in the pharmaceutical industry with credible partnerships (Accredited by various healthcare regulatories with State-of-the art facilities and GMP compliant) and outstanding support. We source APIs for global markets and represent trustworthy principals, giving our clients just the best value. We provide our clients with a modern product range while upholding a high standard of project management on the client’s behalf and that of our principals.
Trichem guides its partners by conveying Innovative solutions in different projects to distinguish oneself in the market and we are, with great effort, working on molecules that are going to shape the pharmaceutical industry in coming years.
Our Core-competency is Market Intelligence, through which we design a portfolio for our principals and customers.
Trichem has also integrated a close knit Business Development team that introduces niche Rx, RLDs and OTC products of our overseas principals to the Indian Customers.
Our Partners are accredited by various healthcare regulatories with State-of-the art facilities and GMP compliant.
To be Globally recognized as a Trusted, Reliable and Admired Sourcing Solutions provider in the HealthCare industry.
To Create Sustainable Value for all our Stakeholders.
| API's | CAS Number | Country of Origin | RC no | Valid Upto |
|---|---|---|---|---|
| Clindamycin HCl IP/BP/EP /USP | 21462-39-5 | China | BD-316 | 19-Sep-24 |
| Clindamycin Phosphate IP/USP | 24729-96-2 | China | BD-316 | 19-Sep-24 |
| Topotecan HCl | 119413-54-6 | Taiwan | BD-002212 | 5-Mar-24 |
| Docetaxel Anhydrous IP | 114977-28-5 | Taiwan | BD-002212 | 5-Mar-24 |
| Azacitidine IP | 320-67-2 | Taiwan | BD-002212 | 5-Mar-24 |
| Paclitaxel IP | 33069-62-4 | Taiwan | BD-002235 | 26-Dec-24 |
| Galantamine HBr IP | 1953-04-4 | Taiwan | BD-002235 | 26-Dec-24 |
| Irinotecan HCl Trihydrate IP | 136572-09-3 | Taiwan | BD-002235 | 26-Dec-24 |
| Gemcitabine HCl IP | 122111-03-9 | Taiwan | BD-002235 | 26-Dec-24 |
| Doxorubicin HCl IP | 25316-40-9 | Germany | BD-002524 | 1-Jul-24 |
| Epirubicin HCl EP | 56390-09-1 | Germany | BD-002524 | 1-Jul-24 |
| Mometasone Furoate IP | 83919-23-7 | Italy | BD-002426 | Under Renewal |
| Moxonidine micronized EP (non-sterile) | 75438-57-2 | Czech Republic | BD-1036 | 20-Jun-24 |
| Alfuzosin HCl IP | 81403-68-1 | Czech Republic | BD-1036 | 20-Jun-24 |
| Tacrolimus IP/USP | 104987-11-3 | Taiwan | 002671 | 29-May-26 |
CAS No : 13171-25-0
Molecular formula : C14H22N2O3, 2HCl
Molecular weight : 339.3
Category : Antianginal Drug
CAS No : 95635-55-5
Molecular formula : C24H33N3O4
Molecular weight : 427.536
Category : Antianginal Drug
CAS No : 77-36-1
Molecular formula : C14H11CLN2O4S
Molecular weight : 338.76
Category : Diuretic Drug
